Study Hints at 'Super' Cholesterol Drug
Posted on: Monday, 26 March 2007, 15:00 CDT
A remarkable 52-milligram decline in a form of blood fat occurred by combining cholesterol drugs simvastatin and fenofibrate, says a U.S. study.
Researchers at the 56th annual scientific sessions of the American College of Cardiology in New Orleans said that an even more robust response might be achieved with using higher doses of simvastatin.
A 20 milligram-dose of the drug sold as Zocor was used in the year-long trial among patients with diabetes, said Heidi May, an epidemiologist at LDS Hospital at the University of Utah, Salt Lake City.
We saw a 52 milligram reduction from baseline in triglycerides when simvastatin was added to treatment, she told United Press International at her presentation.
May tested both drugs individually and in combination among 300 patients. The cholesterol-lowering of simvastatin was enhanced by about 10 mg when fenofibrate was co-administrated, while the cholesterol-lowering effects of fenofibrate was increased by 36 mg when simvastatin was added.
She told UPI that her trial is part of the process that could result in the development of a dual action treatment against cholesterol.
Source: United Press International
Related Articles
- Cholesterol Drug Lowers Risk Of Amputation For Diabetics
- Sciele Expects to Launch Six Products in 2008; Reaffirms Revenue and EPS Guidance for Full-Years 2007 and 2008
- Solvay's Fenofibrate May Prevent Diabetic Eye Diseases
- LifeCycle Pharma and Sciele Pharma Announce FDA Approval of New Formulation of Fenofibrate in 120 Mg. And 40 Mg. Dosage Strengths
- Making Baby's Food is Easier Than You Think and More Nutritious, Too
- The Snacks Before Christmas: For Santa, Cookies and Milk. For You, Chocolate-Raspberry Fondue and Shrimp Dijonnaise. Who?S a Jolly Old Elf
- ESSENTIAL WATER: Make Sure You Get Enough
- Management of Hypertension and Hypercholesterolaemia in Primary Care in the Netherlands*
- Cholesterol Targeting Alters Lipid Raft Composition and Cell Survival in Prostate Cancer Cells and Xenografts
 |
 |
User Comments (0)
RSS Feeds